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Healing Delays in Diabetes and Aging by Activation
of Rac1
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Phil Stephens2, Andrew J. Harrison3 and Mark D. Bass1,4
Chronic skin-healing defects are one of the leading challenges to lifelong well-being, affecting 2–5% of
populations. Chronic wound formation is linked to age and diabetes and frequently leads to major limb
amputation. Here we identify a strategy to reverse ﬁbroblast senescence and improve healing rates. In healthy
skin, ﬁbronectin activates Rac1 in ﬁbroblasts, causing migration into the wound bed, and driving wound
contraction. We discover that mechanical stimulation of the skin with ultrasound can overturn healing defects by
activating a calcium/CamKinaseII/Tiam1/Rac1 pathway that substitutes for ﬁbronectin-dependent signaling and
promotes ﬁbroblast migration. Treatment of diabetic and aged mice recruits ﬁbroblasts to the wound bed and
reduces healing times by 30%, restoring healing rates to those observed in young, healthy animals. Ultrasound
treatment is equally effective in rescuing the healing defects of animals lacking ﬁbronectin receptors, and can be
blocked by pharmacological inhibition of the CamKinaseII pathway. Finally, we discover that the migration
defects of ﬁbroblasts from human venous leg ulcer patients can be reversed by ultrasound, demonstrating that
the approach is applicable to human chronic samples. By demonstrating that this alternative Rac1 pathway can
substitute for that normally operating in the skin, we identify future opportunities for management of chronic
wounds.
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INTRODUCTION
Chronic healing defects are one of the largest current health
challenges, affecting over 6.5 million patients in the United
States and costing over US$25 billion annually (Sen et al.,
2009). The major risk factors are diabetes, age, obesity, and
smoking (Galiano and Mustoe, 2007; Sen et al., 2009),
meaning that the challenge of treating chronic wounds is
escalating as the risk factors become more common. Current
approaches to wound treatment such as debridement
and antibiotic treatment to reduce infection and pressure
treatment to increase blood ﬂow are effective in some, but not
in all cases. Topical application of growth factors to activate
cells has been disappointing because of the abundance of
proteolytic enzymes in a chronic wound, and, although
injection of mesenchymal stem cells or modiﬁed ﬁbroblasts is
effective, it is prohibitively expensive (Woodley et al., 2007;
Zahorec et al., 2014). Therefore, it is important that we
discover ways to manipulate cell types already in situ. Acute
wound closure can be divided into four main processes:
inﬂammation, ﬁbroblast-dependent wound contraction, re-
epithelialization, and angiogenesis (Shaw and Martin, 2009).
Delays in the healing of acute wounds lead to the formation of
chronic wounds, and examination of the cellular defects of
chronic wounds highlights a chronic inﬂammatory response
and ﬁbroblast senescence as the two key defects (Harding
et al., 2005; Menke et al., 2007; Wall et al., 2008). Although
current wound therapy focuses on management of bacterial
burden and the inﬂammatory response, effective strategies for
manipulating the ﬁbroblast population are still lacking
(Galiano and Mustoe, 2007).
Upon wounding, ﬁbronectin deposited by macrophages
or leaking from damaged blood vessels (Shaw and Martin,
2009) engages α5β1-integrin and syndecan-4 on the surface
of ﬁbroblasts, activating the Rac1 pro-migratory signal
(Bass et al., 2007). Knockout of syndecan-4 or ﬁbroblast-
speciﬁc knockout of Rac1 retards wound closure
(Echtermeyer et al., 2001; Liu et al., 2009), whereas topical
application of ﬁbronectin or overexpression of constitutively
active Rac1 accelerates cutaneous repair (Hassanain et al.,
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2005; Kwon et al., 2007). Rac1 has a central role in most cell
migration processes and can be activated by a large number
of guanine nucleotide exchange factors (GEFs) downstream of
a number of signaling pathways (Raftopoulou and Hall,
2004). The range of regulatory mechanisms means that it may
be possible to activate Rac1 in skin ﬁbroblasts and drive
migration by pathways other than the ﬁbronectin-dependent
route. One possibility is to use mechanical, rather than
chemical stimuli to activate Rac1. Indeed, stimulation of
cultured ﬁbroblasts with ultrasound activates Rac1 by a
syndecan-4–independent mechanism (Mahoney et al., 2009).
Interestingly, clinical trials have revealed that ultrasound
accelerates fracture repair by 30–40% (Heckman et al., 1994;
Kristiansen et al., 1997) by promoting endochondral
ossiﬁcation (Azuma et al., 2001; Leung et al., 2004), and
this approach has received approval for clinical fracture
therapy from the Food and Drug Administration (US Food and
Drug Administration) in 1994 and NICE (UK National Institute
for Health and Care Excellence) in 2013. However, the
possibility that ultrasound might also accelerate soft tissue
repair has not been investigated.
In this study, we identify a mechanism of Rac1 activation
that can substitute for the ﬁbronectin-dependent pathway that
operates in healing of healthy skin. We demonstrate that
activation of the pathway by mechanical stimulation, with
ultrasound, rescues healing defects caused by diabetes, age,
or defects in ﬁbronectin signaling by enhancing wound
ﬁbroblast migration. We go on to show that such treatments
have similar effects on patient chronic wound ﬁbroblasts,
indicating that such approaches could be efﬁcacious in
clinical situations.
RESULTS AND DISCUSSION
Acceleration of dermal repair in impaired healing models
To examine the effect of mechanical stimuli on dermal wound
closure, we compared the effect of a 20-minute daily
ultrasound treatment, proven to be efﬁcacious for fracture
repair (30 mWcm-2, 1.5MHz wave frequency, 1 kHz pulse
frequency), with a sham treatment where the device was
applied, but not activated. In the absence of a true chronic
wound animal model, diabetic mice are the most commonly
used impaired healing murine model (Ansell et al., 2012).
Non-obese diabetic mice that spontaneously develop type-1
diabetes (Atkinson and Leiter, 1999) suffered a delay in the
closure of 4-mm full-thickness skin punch wounds, compared
with non-diabetic mice (Figure 1a). Wound size was signi-
ﬁcantly reduced at days 6 and 7 in diabetic mice that received
ultrasound treatment (Figure 1a and b), and treatment reduced
the wound resolution time, at which the scab fell off, from 9 to
6 days (Figure 1c). Therefore, ultrasound stimulation reduced
healing times by 33% and restored the healing mechanisms of
diabetic animals to those observed in healthy controls. Age is
a second key risk factor in poor healing prognosis. The effect
on 18-month-old mice was even more pronounced, with
signiﬁcant healing retardation of untreated mice at days 3–9,
compared with 3-month-old or ultrasound-treated 18-month-
old mice (Figure 1d and e). Again, ultrasound reduced the
wound resolution time from 9 to 6 days (Figure 1f). These
results clearly demonstrate that daily ultrasound treatment
assists wound closure in terms of both wound size, and the
time taken for wounds to resolve to levels indistinguishable
from young mice.
The effect of ultrasound on wound area caused us to
examine the effect on early wound responses, namely
inﬂammation and wound contraction by ﬁbroblasts. Ultra-
sound treatment increased the number of ﬁbroblast-speciﬁc
protein-positive ﬁbroblast cells at the wound shoulder at 72
hours post wounding (Figure 1g and h and Supplementary
Figure S1A and B online), whereas F4/80 staining of
macrophages (Figure 1i and j and Supplementary Figure
S1C and D online) or ﬁbronectin deposition (Supplementary
Figure S1E online) was unaffected by ultrasound. Therefore,
we conclude that ultrasound restores healing to diabetic and
aged animals by activating ﬁbroblasts. The ﬁnding ﬁts with
our clinical understanding of defective healing in diabetes,
which has been attributed to ﬁbroblast senescence and loss of
migratory response, as well as neuropathy and ischemia
(Falanga, 2005). These ﬁndings caused us to look more
closely at the effect of ultrasound on ﬁbroblast behavior.
Fibroblast migration is guided by engagement of the
ﬁbronectin receptors, α5β1-integrin and syndecan-4, which
leads to activation of the protrusive signal, Rac1, and is
required for efﬁcient wound closure (Echtermeyer et al., 2001;
Bass et al., 2007; Liu et al., 2009). We have previously
demonstrated that ultrasound activates Rac1 in syndecan-4-
null ﬁbroblasts and drives linear migration in the absence of a
ﬁbronectin guidance cue (Mahoney et al., 2009). Therefore,
we examined whether ultrasound can rescue the healing
defects of Sdc4− /− mice. Sdc4− /− mice suffer a healing delay
compared with wild type, although it is not as severe as that of
the diabetic and aged mice (Figure 1k). Ultrasound treatment
accelerated wound closure rate and reduced resolution time
of Sdc4− /− mice (Figure 1k–m) and speciﬁcally drove
recruitment of ﬁbroblasts (Figure 1n and Supplementary
Figure S2A and B online). By contrast, ultrasound had no
effect on wild-type animals, which already healed efﬁciently
(Supplementary Figure S2C and G online). Taken together, we
demonstrate that the mechanical ultrasound stimulus acti-
vates ﬁbroblasts and overcomes wound-healing defects in
both pathological and speciﬁc knockout mouse models.
Ultrasound induces persistent migration
In the dermis, collagen and ﬁbronectin are arranged into
aligned ﬁbers that act as guidance cues and cause linear
migration of ﬁbroblasts. An in vitro approximation of this
matrix structure can be generated by lysing ﬁbroblasts from a
cultured monolayer to yield exposed cell-derived matrix.
Cell-derived matrix allows detailed analysis of the ability of
individual migrating cells to follow ﬁbers, and migration
persistence can be calculated by dividing linear displacement
of a cell by total distance moved. Wild-type cells migrate
persistently over cell-derived matrix, whereas Sdc4-/- ﬁbro-
blasts migrate randomly, due to dysregulated Rac1 signaling
(Bass et al., 2007). Ultrasound stimulation of wild-type
ﬁbroblasts had no effect on speed, and did not signiﬁcantly
increase the persistence, as wild-type ﬁbroblasts already
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exhibit linear migration (Figure 2a–c and Supplementary
Movie S1 online). Although ultrasound did not affect the
speed of Sdc4− /− ﬁbroblasts, it caused the cells to switch from
random to persistent migration (Figure 2d–f), consistent with
the recruitment of ﬁbroblasts to the wound shoulder seen
in vivo (Figure 1m and Supplementary Figure S2A online). To
test whether the migration effect is applicable to human
chronic wound samples, we repeated the experiment using
senescent-like ﬁbroblasts isolated from the chronic venous leg
ulcer of a 71-year-old female patient with wound duration of
greater than 7 months. With the venous leg ulcer ﬁbroblasts,
the effect of ultrasound was even more signiﬁcant than
Sdc4− /− ﬁbroblasts, increasing both the speed and persis-
tence of migration (Figure 2g and i and Supplementary Movie
S2 online). The increase in severity of the migration defect of
the chronic sample compared with the Sdc4− /− sample
matches the greater effect on healing seen with aged or
diabetic mice, compared with Sdc4− /−. Importantly, these
results show that, although pathological defects are more
severe compared with simple knockout models, ultrasound is
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Figure 1. Rescue of defective healing in mouse models. 4-mm full-thickness punch wounds on mice with characterized healing defects or matched controls
were subjected to daily ultrasound (US) or sham treatments and wound closure was recorded. (a–c, g, and i) Diabetic (non-obese diabetic (NOD)). (d–f, h, and j)
18-month and 3-month old. (k–n) Sdc4− /− and Sdc4+/+. (a, b, d, e, k, and l) Daily macroscopic images and measurements of wound area. (c, f,m) Animals scored
for loss of the scab as an indicator of wound resolution. (g–j, n) Skin sections stained for ﬁbroblast-speciﬁc protein (FSP) and macrophages (F4/80) at 72 hours post
wounding, and scored for ﬁbroblast or macrophage number per ﬁeld of view. Example images shown in Supplementary Figures S1 and S2a,B+ E - F online. Data
are representative of 12 wounds in 6 mice per condition. Error bars indicate SEM. Signiﬁcance tested by Student's t-test, *Po0.05, **Po0.005. NS, not signiﬁcant.
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capable of reactivating ﬁbroblasts and restoring both and
hence is broadly applicable.
Alternative Rac1 activation mechanisms
We know that Rac1 activation is a key event in skin repair,
and that engagement of syndecan-4 by ﬁbronectin activates
Rac1 in healthy skin ﬁbroblasts. We also know that ultra-
sound negates the need for syndecan-4 in wound healing, and
hence we tested whether ultrasound was activating Rac1 by
an alternative pathway. Rac1 is activated by exchange of
bound GDP for GTP, governed by the activity of GEFs
(Raftopoulou and Hall, 2004), and therefore we tested the role
of a number of GEFs in mediating the ultrasound signal,
using effector pull-down assays. Ultrasound elicited a wave of
Rac1 activity in control knockdown mouse embryonic
ﬁbroblasts (MEFs) (Figure 3a). Reducing the ultrasound
intensity attenuated the 30-minute peak in Rac1 activity,
conﬁrming that the Rac1 response was indeed a consequence
of the ultrasound wave (Supplementary Figure 3A online).
Rac1 activation was not blocked by RNA interference of
Rac-GEFs, Vav2, or Dock180 (Figure 3b and c, f). By contrast,
Rac1 activation was ablated in Tiam1− /− MEFs, and could be
rescued by re-expression of Tiam1 (Figure 3d and f). To
ensure that ultrasound stimulation was coupled to signaling
downstream of Rac1, phosphorylation of p21-activated kinase
1 (PAK) was measured by in-cell ELISA. Ultrasound induced
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Figure 2. Restoration of defective ﬁbroblast migration. Sham- or ultrasound (US)-treated wild-type (a–c), Sdc4− /− (d–f), or chronic venous leg ulcer ﬁbroblasts
(g–i) were seeded onto ﬁbrous cell-derived matrix and migration tracked over 16 hours. (a, d and g) Example tracks. (b, e and h) Average migration speed (total
distance moved/time). (c, f and i) Average persistence of migration (total displacement/total distance moved, so that for perfect linear migration, persistence=1).
Error bars indicate SEM, n= 60 per condition. Signiﬁcance tested by Kruskal–Wallis test, **Po0.005, ***Po0.0005. NS, not signiﬁcant.
JA Roper et al.
Ultrasound Restores Defective Skin Healing
www.jidonline.org 2845
**
3010
Stim time (min)
2.0
1.5
1.0
0
0
0.5
Ac
tiv
e 
R
ac
1
60 90
30100 60 90
30100 60 90
30100 60 90
30100 60 90 30100 60 90
30100 60 90 30100 60 90
30100 60 90
30100 60 90
30100 60 30100 60
30100 60
90
30100 60 9030100 60 90
Control
*
Stim time (min)
2.0
1.5
1.0
0
0.5
Ac
tiv
e 
R
ac
1
Vav2 KD
Stim time (min)
2.0
1.5
1.0
0
0.5
Ac
tiv
e 
R
ac
1
Dock180 KD
*
Stim time (min)
2.0
1.5
1.0
0
0.5
Ac
tiv
e 
R
ac
1
Tiam1 –/–
Stim time (min)
3.5
2.5
1.5
0
0.5
Ac
tiv
e 
R
ac
1
Tiam1 rescue
3.0
2.0
1.0
**
**
Stim time (min)
2.0
1.5
1.0
0
0.5P
ho
sp
ho
 P
AK
Control
**
Stim time (min)
2.0
1.5
1.0
0
0.5P
ho
sp
ho
 P
AK
Vav2 KD
Stim time (min)
2.0
1.5
1.0
0
0.5P
ho
sp
ho
 P
AK
Tiam1 –/–
**
Stim time (min)
2.0
1.5
1.0
0
0.5P
ho
sp
ho
 P
AK
Dock180 KD
Stim time (min)
5.0
4.0
0
1.0
Ph
os
ph
o 
PA
K
Tiam1 rescue
3.0
**
GTP-rac1
Tubulin
GTP-rac1
Tubulin
GTP-Rac1
Tubulin
GTP-Rac1
Tubulin
GTP-rac1
Tubulin
Ctrl
Vav2
KD
Vav2
HSP70
Ctrl
Dock180
KD
Dock180
HSP70
–/–
Tiam1:
Rescue
Tiam1
Tubulin
2.0
+/+
a b c
e fd
g
j
h
k
i
Figure 3. Tiam1 mediates Rac1 activation in response to ultrasound. Mouse embryonic ﬁbroblasts (MEFs) were spread on the integrin-binding fragment of
ﬁbronectin, stimulated with ultrasound, and analyzed at the appropriate time from the start of stimulation (Stim). (a–e) Rac1 activity measured by effector pull-
down assay, n=5 per condition. (f) Expression of candidate GEFs in the corresponding experiments following knockdown (KD) or rescue in comparison with
control (Ctrl). (g–k) PAK phosphorylation measured by in-cell ELISA, n= 12 per condition. Error bars indicate SEM. Signiﬁcance tested by analysis of variance,
*Po0.05, **Po0.005.
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PAK phosphorylation that was blocked by knockout of Tiam1,
but not knockdown of other GEFs (Figure 3g–k). Finally,
speciﬁcity of the ultrasound signal was tested by examining
the related GTPase, Cdc42. Ultrasound had no effect on
Cdc42 activity (Supplementary Figure 3B online), demonstrat-
ing a speciﬁc effect on Rac1.
Calmodulin kinase II (CaMKII) mediates the ultrasound response
Tiam1 is activated by phosphorylation by protein kinase C
and CaMKII (Fleming et al., 1999). We have previously
reported that ultrasound functions independently of protein
kinase C (Mahoney et al., 2009), and hence we investigated
the role of CaMKII. Inhibition of CaMKII activity with the
pharmacological inhibitor, KN93, or small interfering RNA
blocked PAK phosphorylation upon ultrasound stimulation
(Figure 4a–c). Furthermore, ultrasound triggered activating
autophosphorylation of CamKII (Thr286) demonstrating that
CamKII mediates the ultrasound effect (Figure 4d).
CaMKII is itself activated by association with calcium-
bound calmodulin (Swulius and Waxham, 2008), leading us
to test whether calcium levels affected the ultrasound
response. Disruption of the intracellular calcium stores
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Figure 4. Calmodulin kinase II (CamKII) mediates Rac1 activation in response to ultrasound. Inhibitor-treated mouse embryonic ﬁbroblasts (MEFs) were
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(thapsigargin), chelation of extracellular calcium (BAPTA (1,2-
bis(o-aminophenoxy)ethane-N,N,N0,N0-tetraacetic acid)), or
chelation of all calcium (membrane permeable, BAPTA-AM
(1,2-bis(2-aminophenoxy)ethane-N,N,N0,N0-tetraacetic acid
tetrakis(acetoxymethyl ester))) each blocked PAK phos-
phorylation in response to ultrasound, demonstrating that
calcium ﬂux has a key role in mediating the ultrasound signal
(Figure 4e). Crucially, thapsigargin and BAPTA had no effect
on PAK phosphorylation in response to ﬁbronectin fragments
(Figure 4f), demonstrating that the cells were still capable of
mounting a response and that ultrasound and ﬁbronectin
activate Rac1 by separate pathways. Collectively, these
experiments identify a calcium-dependent pathway of Rac1
activation that is independent of the ﬁbronectin-triggered
pathway that occurs in healthy ﬁbroblasts (Figure 4g).
Healing signals converge on Rac1
We propose that ultrasound-triggered signals and normal
wound signals converge on the key migration regulator, Rac1,
explaining how ultrasound can rescue wound-healing defects
arising from a number of situations. We tested the hypothesis
by blocking the ultrasound-triggered pathway in our mouse
models. Application of the pharmacological Rac1 inhibitor,
EHT 1864, to wounds on wild-type mice severely retarded
wound contraction and furthermore blocked the ability of
ultrasound to rescue healing, demonstrating that normal and
ultrasound-induced pathways converge on Rac1 (Figure 5a).
Fibronectin-dependent and ultrasound-dependent pathways
were tested using a combination of syndecan-4 knockdown
and pharmacological inhibition of CamKII with KN93. KN93
had no effect on wound closure in wild-type mice where
ﬁbronectin signaling was intact (Figure 5b). However, in
Sdc4− /− mice where ﬁbronectin signaling is perturbed, KN93
blocked the ability of ultrasound to rescue normal wound
closure (Figure 5c). These results demonstrate that Rac1
activation is crucial for efﬁcient wound closure, but that it can
be achieved in different ways. In the absence of signaling
through syndecan-4, stimulation of a CamKII pathway is a
viable route for Rac1 activation and ultrasound treatment
provides a robust mechanism for doing that.
Collectively, our experiments demonstrate that Rac1 can be
activated in wound ﬁbroblasts using a mechanical, ultrasound
stimulus. This calcium-CamKII-Tiam1-mediated pathway can
substitute for the ﬁbronectin-triggered pathway seen during the
healing of healthy skin and restores normal healing to a
number of pathological healing mouse models.
Comparison with the fracture-repair registry
The standout discovery in this manuscript is that healing times
in diabetic or aged mice can be reduced by 33% (Figure 1),
which is comparable with the 30–40% reduction in healing
times of tibial and radial fractures (Heckman et al., 1994;
Kristiansen et al., 1997). The similarity is surprising as the
mechanisms differ. We demonstrate that, in skin healing,
ultrasound stimulates Rac1 signaling and ﬁbroblast migration,
but has no effect on macrophage recruitment. By contrast,
ultrasound in fracture repair has been linked to inﬂammatory
signals and induces COX-2 expression and prostaglandin
E2 secretion (Tang et al., 2006), resulting in differentiation of
mesenchymal cells into osteoblasts and chondrocytes that
leads to endochrondal ossiﬁcation (Pounder and Harrison,
2008). Nevertheless, the rescue of skin healing that we report
matches the reported restoration of delayed fracture healing
caused by diabetes (Coords et al., 2011) or age (Naruse et al.,
2010) in rodents. A second feature of our ﬁndings is that
ultrasound has limited effect on the healing rates of young
healthy mice, which already heal efﬁciently (Supplementary
Figure S2C and D online). Registry studies of clinical
investigations into the use of ultrasound for fracture repair
have revealed similar trends. Although the clinical study by
Heckman et al. (1994) demonstrated that ultrasound acceler-
ated fracture healing in patients by 38%, another study that
excluded risk factors such as smoking and alcohol from the
study group did not ﬁnd a signiﬁcant effect of ultrasound on
fracture repair (Emami et al., 1999). The similarities between
groups that beneﬁt from ultrasound treatment during fracture
and skin repair are encouraging as inspection of a large Food
and Drug Administration-reviewed registry of non-union
fractures treated with ultrasound reveals that although
untreated fractures heal 63–87% less efﬁciently in diabetic
than healthy patients, ultrasound induced closure of non-
unions in 82% (71/87) of diabetics, similar to the 83%
(1283/1546) closure rate observed across the entire registry
(Frankel and Mizuho, 2002). If, as our ﬁndings suggest, the
beneﬁcial effect of ultrasound can be extrapolated from
fracture to skin healing, then a solution to treatment of chronic
wounds would be within our grasp.
An issue that has hindered the clinical use of ultrasound is
that different studies have used a range of ultrasound
parameters with a range of success. Efﬁcacy in fracture repair
has been demonstrated using ultrasound intensities ranging
from 2 to 500mWcm−2 (Claes and Willie, 2007; Angle et al.,
2011), although intensities above 100mW cm−2 have been
reported to result in lower maximum torque in the repaired
bone than intensities of 30–50mWcm−2 (Claes and Willie,
2007). Previous studies into effects on skin healing have been
even more diverse, with most studies examining low-
frequency ultrasound as a form of physiotherapy massage.
One study using high-frequency (3MHz) ultrasound actually
found that treatment retarded healing of ischemic skin ﬂap
wounds in rats (Altomare et al., 2009) but this study applied
ultrasound at 500mW cm−2. At below 50mWcm−2, the
thermal effects of ultrasound are negligible (0.01 °C; Duarte,
1983), but at 500mWcm−2 it would be sufﬁcient to affect
temperature-sensitive enzymes such as matrix metallo-
proteinases and collagenase (Claes and Willie, 2007). It is
logical that an ischemic wound would be more susceptible
to such damage, because of the reduced ability to
dissipate heat.
In this study, we ﬁnd that reduction in ultrasound intensity
attenuates Rac1 activation in ﬁbroblasts (Supplementary
Figure 3A online). By contrast, signals as low as 2mWcm−2
have been reported to be sufﬁcient to trigger differentiation
and mineralization of bone marrow stromal cells (Angle et al.,
2011). One possible explanation would be that mole-
cular mechanisms differ between bone and skin healing, but
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a second would be that a threshold of active Rac1 is required
to activate a cell, and that 2 mWcm−2 is sufﬁcient to reach
that threshold in stromal cells. Indeed, we previously reported
that the threshold for focal adhesion-formation by ﬁbroblasts
is 20–25mW cm−2 (Mahoney et al., 2009). The threshold
differences between cell types mean that the ultrasound dose
needs to be optimized, and is even more complicated in vivo.
Ultrasound is attenuated as it passes through the tissue, and
then reﬂected at the bone-soft tissue interface (Claes and
Willie, 2007). Such effects mean that the same emitter
delivers different intensities of ultrasound to skin compared
with a fracture, and it is probable that the optimal regimes for
treating fractures and skin wounds will differ. Therefore, our
current ﬁndings represent the ﬁrst step toward skin-healing
therapy and there is now great scope and great need for
reﬁnement, to develop the optimal therapeutic regimes for
both skin and bone treatments.
MATERIALS AND METHODS
Animals
Animal experiments were performed in accordance with the Home
Ofﬁce regulations described by the UK Animals (Scientiﬁc Proce-
dures) Act 1986, UK project license 30/2791. Syndecan-4 wild-type
and knockout C57BL/6 J mice (Ishiguro et al., 2000) generated by
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Figure 5. Independent Rac1 activation pathways drive wound closure in mice. 4-mm full-thickness punch wounds on (a and b) wild-type (WT) or (c and d)
Sdc4− /− mice were treated with vehicle of pharmacological inhibitor, 50 μM EHT 1864 (a) or 20 μM KN93 (b–d) in pluronic gel. Wounds were subjected to daily
ultrasound (US) or sham treatments and wound closure was recorded. (d) Rate constants of curves depicted in c. Data are representative of 6 mice per condition.
Error bars indicate SEM. (a) Signiﬁcance of + vs − EHT tested by paired t-test. (c) Signiﬁcance of +KN93+US vs +US tested by paired t-test, *Po0.05,
**Po0.005.
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heterozygous (Sdc4 (+/− ) C57BL/6 J) parental crosses were used at
age 12 weeks for comparison of genotypes. Wild-type mice were used
at 18 months for the aging study. Male non-obese diabetic mice
were maintained in a clean environment to maximize spontaneous
diabetes development. Onset of diabetes was monitored weekly
before experiments by urine glucose measurements (Diastix, Bayer,
Leverkusen, Germany), and daily thereafter until the mice were killed.
Punch wound experiments
Mice were anesthetized by isoﬂuorane inhalation for initial wound-
ing and daily treatment with ultrasound. To create wounds, two pairs
of full-thickness 4-mm excisional punch wounds were made either
side of the dorsal midline of the barbered back of each animal.
Wound size was recorded by photographing mice at the same time
each day before treatment. Where relevant, rate constants of curves
were calculated by ﬁtting a one-phase decay with GraphPad Prism
(GraphPad, La Jolla, CA). For application of drugs, 30% pluronic gel
(Sigma, Dorset, UK) with and without 50 μM EHT 1864 (Sigma) or
20 μM KN93 (Calbiochem, Millipore, Watford, UK) was maintained
as a liquid at 4 °C before it was administered directly to the wound by
pipette immediately after wounding and allowed to solidify.
Ultrasound stimulation
Mouse wounds or cells in culture were coupled to 2.5-cm diameter
ultrasound transducer (Exogen; Bioventus LLC, Durham, NC) using
water-based gel (Exogen). During stimulation experiments, the
transducer generated 30mWcm−2 (spatial average, temporal aver-
age) pulsed ultrasound with a 1.5-MHz wave frequency, pulsed at
1 kHz for a duration of 20minutes. For sham treatments, the
transducer was applied, but not activated. For intensity investiga-
tions, a similar device with variable power output (30, 15, 6, and
2mWcm−2) was used.
Immunohistochemistry
Ten-micrometer sections of 4% paraformaldehyde-ﬁxed, parafﬁn-
embedded skin were immunostained with antibodies against
ﬁbroblast-speciﬁc protein 1 and macrophage marker, F4/80 (Abcam,
Cambridge, UK) and ﬁbronectin (Millipore, Watford, UK). Primary
antibody binding was visualized with biotinylated secondary anti-
body, ABC-HRP conjugate, and 3,3-diaminobenzidine developing
reagent (Vector Laboratories, Peterborough, UK), and sections were
counterstained with hematoxylin (Sigma).
Cell culture
Tiam1 wild-type and knockout MEFs were cultured at 37 °C in
DMEM, 10% fetal bovine serum, 4.5 g l− 1 glucose, and 2mM
L-glutamine. Immortalized wild-type and syndecan-4-knockout
MEFs, generated as previously described (Bass et al., 2007), were
cultured at 33 °C to preserve temperature-dependent expression of
large T antigen-driven immortality in DMEM, 10% fetal bovine
serum, 4.5 g l− 1 glucose, 2 mML-glutamine and 20 Uml−1 IFN-γ
(Sigma). Chronic wound ﬁbroblasts were obtained from tissue
biopsies after approval from the Local Research Ethics Committee
(09/WSE03/19) and written informed consent from patients with non-
healing, chronic venous leg ulcers attending the Wound Healing
Clinic at the University Hospital of Wales, Cardiff. Only patients with
wounds who failed to respond to conventional treatment regimes
after 2 months were used in the study. Chronic wound ﬁbroblasts
were isolated and cultured as described previously (Cook et al.,
2000). Telomerase-immortalized human ﬁbroblasts were cultured at
37°C in DMEM, 15% fetal bovine serum, 4.5 g l− 1 glucose, 25mM
HEPES, and 2mML-glutamine.
Small interfering RNA duplexes with ON TARGET modiﬁcation,
targeting the sense strand of mouse Vav2 (5′-CAAAUGGGCGGAUC
GGUUGUU-3′) and Dock180 (5′-GAUAUUGAUCGGUUACAUA
UU-3′), were purchased from Dharmacon (Thermo Fisher Scientiﬁc,
Little Chalfont, UK). For knockdown of CamKII, both A and B
subunits were targeted by endonuclease-prepared siRNA (Sigma).
Small interfering RNAs were transfected into immortalized MEFs over
two rounds using Dharmafect2 reagent (Thermo Fisher Scientiﬁc).
Expression of target proteins in comparison with mock-transfected
cells was tested by western blotting.
Migration analysis
Cell-derived matrix was prepared as described previously by
culturing conﬂuent ﬁbroblasts for 10 days before removing the
ﬁbroblasts by NH4OH lysis (Bass et al., 2007). For migration, cells
were seeded at 5,000 cells per ml and allowed to spread for 4 hours
before capturing time-lapse images at 10-minute intervals for 16
hours on a Leica AS MDW microscope (Leica, Milton Keynes, UK)
using a × 5, numerical aperture 0.15 Fluotar objective and Roper
(Sarasota, FL) CCD camera. The migration paths of all non-dividing,
non-clustered cells were tracked using ImageJ software (NIH,
Bethesda, MD). Persistence was calculated by dividing linear
displacement of a cell over 10 hours by the total distance migrated.
Cell spreading for biochemical assays
GTPase and PAK-activation assays were conducted on surfaces coated
with a recombinant ﬁbronectin polypeptide encompassing type III
repeats 6–10 that comprises the α5β1-integrin ligand (Bass et al., 2007).
Six-well or 96-well tissue culture-treated plastic dishes (Corning BV,
Wiesbaden, Germany) were coated overnight at 4 °C with 20 μgml−1
50 K in Dulbecco's PBS containing calcium and magnesium (Sigma),
and blocked with 10mgml−1 heat-denatured BSA. To prevent de novo
synthesis of ECM and other syndecan-4 ligands, cells were treated
with 25 μgml−1 cycloheximide (Sigma) for 2 hours before the assay.
Cells were spread on the 50 K-coated plates for 2 hours in DMEM,
4.5 g l−1 glucose, 25mM HEPES, and 25 μgml−1 cycloheximide.
Spread cells were stimulated with ultrasound (30mWcm-2, 1.5MHz
wave frequency, and 1 kHz pulse frequency), or the syndecan-4-
binding fragment of ﬁbronectin (Bass et al., 2007). Where
appropriate, pharmacological inhibitors were included throughout
spreading and stimulation: 20 μM KN93 (Calbiochem), 200 nM
Thapsigargin (Calbiochem), 50 μM BAPTA, and 50 μM BAPTA-AM)
(Life Technologies, Paisley, UK).
GTPase activity assays
Cells were lysed in 20mM HEPES (pH 7.4), 10% (v/v) glycerol,
140mM NaCl, 1% (v/v) Nonidet P-40, 0.5% (w/v) sodium
deoxycholate, 4 mM EGTA, 4 mM EDTA, and cOmplete protease
inhibitor (Roche, Burgess Hill, UK). GST-PAK-CRIB-loaded agarose
beads were incubated with the lysates for 1 hour and then washed
three times with lysis buffer. Bound proteins were blotted for Rac1 or
Cdc42 (BD Transduction Labs, Oxford, UK).
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In-cell ELISA
Cells ﬁxed in 4% paraformaldehyde were permeablized with 0.1%
Triton X-100 in Tris-buffered saline (TBS) and blocked to reduce non-
speciﬁc binding (Sigma, casein block in TBS). Anti-phospho-
Serine141 PAK1/2/3 antibody (Life Technologies, diluted 1:800 in
TBS block was applied to each well overnight. Cells were washed in
TBS containing 0.1% Tween-20 and primary antibody binding was
visualized with Alexa Fluor 800-conjugated anti-rabbit IgG diluted
1:5,000 in TBS block. Wells were washed of unbound secondary
antibody and the plates scanned quantiﬁed (Odyssey ﬂuorescent
detection system, LI-COR Biosciences, Lincoln, NE).
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